UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer

Science translational medicine, 2019-08, Vol.11 (504)

2019

Volltextzugriff (PDF)

The association of genomic lesions and PD-1/PD-L1 expression in resected triple-negative breast cancers

Breast cancer research : BCR, 2018-07, Vol.20 (1), p.71-71, Article 71

2018

Volltextzugriff (PDF)

Obstructive rectosigmoid colon solitary extramedullary plasmacytoma

Digestive and liver disease, 2021-04, Vol.53 (4), p.496-497

2021

Volltextzugriff (PDF)

Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer

Oncotarget, 2015-09, Vol.6 (28), p.26483-26493

2015

Volltextzugriff (PDF)

Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 Adjuvant Trastuzumab Trial

Journal of clinical oncology, 2015-03, Vol.33 (7), p.701-708

2015

Volltextzugriff (PDF)

Deep clonal profiling of formalin fixed paraffin embedded clinical samples

PloS one, 2012-11, Vol.7 (11), p.e50586-e50586

2012

Volltextzugriff (PDF)

Impact of PTEN Protein Expression on Benefit From Adjuvant Trastuzumab in Early-Stage Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the North Central Cancer Treatment Group N9831 Trial

Journal of clinical oncology, 2013-06, Vol.31 (17), p.2115-2122

2013

Volltextzugriff (PDF)

Atypical Ductal Hyperplasia on Core Biopsy: An Automatic Trigger for Excisional Biopsy?

Annals of surgical oncology, 2012-10, Vol.19 (10), p.3264-3269

2012

Volltextzugriff (PDF)

Androgen Receptor-Positive Triple Negative Breast Cancer: A Unique Breast Cancer Subtype

Annals of surgical oncology, 2014-02, Vol.21 (2), p.361-367

2014

Volltextzugriff (PDF)

A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)

The oncologist (Dayton, Ohio), 2019-05, Vol.24 (5), p.589-e160

2019

Volltextzugriff (PDF)

Unique evolutionary trajectories of breast cancers with distinct genomic and spatial heterogeneity

Scientific reports, 2021-05, Vol.11 (1), p.10571-10571, Article 10571

2021

Volltextzugriff (PDF)

Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial

Journal of clinical oncology, 2016-04, Vol.34 (10), p.1034-1042

2016

Volltextzugriff (PDF)

A Rare Intracranial Collision Tumor of Meningioma and Metastatic Uterine Adenocarcinoma: Case Report and Literature Review

World neurosurgery, 2021-01, Vol.145, p.340-347

2021

Volltextzugriff (PDF)

ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer

BMC cancer, 2014-10, Vol.14 (1), p.749-749, Article 749

2014

Volltextzugriff (PDF)

Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D)

European journal of cancer (1990), 2021-05, Vol.148, p.287-296

2021

Volltextzugriff (PDF)

Central pathology laboratory review of HER2 and ER in early breast cancer: an ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring study

Breast cancer research and treatment, 2014-02, Vol.143 (3), p.485-492

2014

Volltextzugriff (PDF)

Predictability of Adjuvant Trastuzumab Benefit in N9831 Patients Using the ASCO/CAP HER2-Positivity Criteria

JNCI : Journal of the National Cancer Institute, 2012-01, Vol.104 (2), p.159-162

2012

Volltextzugriff (PDF)

Development and validation of a novel clinical fluorescence in situ hybridization assay to detect JAK2 and PD-L1 amplification: a fluorescence in situ hybridization assay for JAK2 and PD-L1 amplification

Modern pathology, 2017-11, Vol.30 (11), p.1516-1526

2017

Volltextzugriff (PDF)

Clinicopathologic features of breast cancers that develop in women with previous benign breast disease

Cancer, 2016-02, Vol.122 (3), p.378-385

2016

Volltextzugriff (PDF)

Progression of pelvic implants to complex atypical endometrial hyperplasia after uterine morcellation

Obstetrics and gynecology (New York. 1953), 2011-02, Vol.117 (2 Pt 2), p.447-449

2011

Volltextzugriff (PDF)

Characterizing Occult Nodal Disease Within a Clinically Node-Negative, Neoadjuvant Breast Cancer Population

Clinical breast cancer, 2022-02, Vol.22 (2), p.186-190

2022

Volltextzugriff (PDF)

Chevalerie et royauté dans le roman d'Erec de Hartmann von Aue by Patrick Del Luca (review)

Arthuriana (Dallas, Tex.), 2023-09, Vol.33 (3), p.108-109

Mccullough, Ann

2023

Volltextzugriff (PDF)

MR imaging of hypervascular liver masses: a review of current techniques

Radiographics, 2009-03, Vol.29 (2), p.385-402

2009

Volltextzugriff (PDF)

A Case of Sustained Viral Shedding of Mpox With Ocular Involvement Resulting in Vision Loss

Open forum infectious diseases, 2024-01, Vol.11 (1), p.ofad632

2024

Volltextzugriff (PDF)

Back to Basics: Traditional Nottingham Grade Mitotic Counts Alone are Significant in Predicting Survival in Invasive Breast Carcinoma

Annals of surgical oncology, 2015-12, Vol.22 (Suppl 3), p.509-515

2015

Volltextzugriff (PDF)

1 – 25 von 328

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(279)
Mit Volltextzugriff
(248)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(328)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(170)
Life Sciences & Biomedicine
(155)
Humans
(139)
Female
(101)
Middle Aged
(78)
Male
(72)
Adult
(67)
Aged
(64)
Biological And Medical Sciences
(57)
Medical Sciences
(48)
Oncology
(39)
Tumors
(30)
Aged, 80 And Over
(28)
Prospective Studies
(27)
Risk Factors
(27)
Biopsy
(24)
Breast Cancer
(24)
Gastroenterology & Hepatology
(23)
Gastroenterology. Liver. Pancreas. Abdomen
(21)
Public, Environmental & Occupational Health
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Hepatology
(10)
Journal Of Clinical Oncology
(9)
Cancer Epidemiology, Biomarkers & Prevention
(8)
Cancer Research
(7)
Annals Of Surgical Oncology
(6)
Arthuriana
(6)
Blood
(5)
Cancer
(5)
Clinical Cancer Research
(5)
Plos One
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer

The association of genomic lesions and PD-1/PD-L1 expression in resected triple-negative breast cancers

Obstructive rectosigmoid colon solitary extramedullary plasmacytoma

Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer

Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 Adjuvant Trastuzumab Trial

Deep clonal profiling of formalin fixed paraffin embedded clinical samples

Impact of PTEN Protein Expression on Benefit From Adjuvant Trastuzumab in Early-Stage Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the North Central Cancer Treatment Group N9831 Trial

Atypical Ductal Hyperplasia on Core Biopsy: An Automatic Trigger for Excisional Biopsy?

Androgen Receptor-Positive Triple Negative Breast Cancer: A Unique Breast Cancer Subtype

A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)

Unique evolutionary trajectories of breast cancers with distinct genomic and spatial heterogeneity

Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial

A Rare Intracranial Collision Tumor of Meningioma and Metastatic Uterine Adenocarcinoma: Case Report and Literature Review

ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer

Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D)

Central pathology laboratory review of HER2 and ER in early breast cancer: an ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring study

Predictability of Adjuvant Trastuzumab Benefit in N9831 Patients Using the ASCO/CAP HER2-Positivity Criteria

Development and validation of a novel clinical fluorescence in situ hybridization assay to detect JAK2 and PD-L1 amplification: a fluorescence in situ hybridization assay for JAK2 and PD-L1 amplification

Clinicopathologic features of breast cancers that develop in women with previous benign breast disease

Progression of pelvic implants to complex atypical endometrial hyperplasia after uterine morcellation

Characterizing Occult Nodal Disease Within a Clinically Node-Negative, Neoadjuvant Breast Cancer Population

Chevalerie et royauté dans le roman d'Erec de Hartmann von Aue by Patrick Del Luca (review)

MR imaging of hypervascular liver masses: a review of current techniques

A Case of Sustained Viral Shedding of Mpox With Ocular Involvement Resulting in Vision Loss

Back to Basics: Traditional Nottingham Grade Mitotic Counts Alone are Significant in Predicting Survival in Invasive Breast Carcinoma

Suchergebnisse filtern